how do response rates observed in clinical trials translate into real-world outcomes in mm?
Published 6 months ago • 128 plays • Length 8:06Download video MP4
Download video MP3
Similar videos
-
1:11
measuring treatment response rates in multiple myeloma
-
2:20
do results obtained in clinical trials translate accurately in real world practice?
-
7:13
understanding clinical trials in myeloma
-
59:53
clinical trials in multiple myeloma
-
7:18
response rate on phase 1/2 trial regn5458 (bcmaxcd3 bispecific antibody) for rrmm patients
-
1:04:33
coordinating better outcomes in multiple myeloma
-
1:45
clinical translation of carfilzomib trial data for mm treatment
-
2:27
addressing the disparity in ethnic variation in uk-based clinical trials for multiple myeloma
-
5:15
promising clinical trials for multiple myeloma: karmma, cartitude and evolve
-
5:11
what is the response criteria in myeloma?
-
2:03
total therapy 7: high response rates in high risk ndmm to daratumumab
-
2:15
real-world analysis in treatment approaches for multiple myeloma
-
1:28
real-world experience: ide-cel for r/r multiple myeloma
-
5:22
updates on german clinical trials in multiple myeloma
-
2:19
update on eloquent-2: phase 3 trial of elotuzumab in relapsed/refractory multiple myeloma
-
8:12
effectiveness and safety of ixazomib-based therapy in rrmm outside of a clinical trial: uvea ixa
-
2:15
assessment of response in multiple myeloma: next steps
-
1:11:51
addressing myeloma disparities | mcrt webcast february 26, 2022
-
46:01
clinical trials for multiple myeloma patients (selinexor, car t cell) | donna’s story